{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:34:32Z","timestamp":1789169672325,"version":"build-2803163510"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300871"],"award-info":[{"award-number":["82300871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360603"],"award-info":[{"award-number":["82360603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560157"],"award-info":[{"award-number":["82560157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007846","name":"Yunnan Provincial Department of Education","doi-asserted-by":"publisher","award":["2025Y0380"],"award-info":[{"award-number":["2025Y0380"]}],"id":[{"id":"10.13039\/501100007846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2025S090"],"award-info":[{"award-number":["2025S090"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["2024XKTDYS03"],"award-info":[{"award-number":["2024XKTDYS03"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["RCYX20221008092911040"],"award-info":[{"award-number":["RCYX20221008092911040"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515220157"],"award-info":[{"award-number":["2024A1515220157"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.critrevonc.2026.105222","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:09:40Z","timestamp":1771358980000},"page":"105222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["cGAS\u2013STING signaling pathway in urogenital oncology: Regulation, resistance, and routes to response"],"prefix":"10.1016","volume":"221","author":[{"given":"Chen","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senmao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enxiu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.critrevonc.2026.105222_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/2326-6066.CIR-17-0049","article-title":"Intratumoral STING activation with T-cell checkpoint modulation generates systemic antitumor immunity","volume":"5","author":"Ager","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105222_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009368","article-title":"Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy","volume":"12","author":"Al-Janabi","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"7689","key":"10.1016\/j.critrevonc.2026.105222_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature25432","article-title":"Chromosomal instability drives metastasis through a cytosolic DNA response","volume":"553","author":"Bakhoum","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105222_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(21)00147-9","article-title":"Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study","volume":"22","author":"Balar","year":"2021","journal-title":"Lancet Oncol."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105222_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193745","article-title":"CDK12\/13 inactivation triggers STING-mediated antitumor immunity in preclinical models","volume":"135","author":"Bao","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105222_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/BST20220838","article-title":"cGAS-STING signalling in cancer: striking a balance with chromosomal instability","volume":"51","author":"Beernaert","year":"2023","journal-title":"Biochem Soc. Trans."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105222_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70044","article-title":"Epigenome-wide association study of prostate cancer in African American men identified differentially methylated genes","volume":"13","author":"Berglund","year":"2024","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105222_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114122","article-title":"HSV-1 employs UL56 to antagonize expression and function of cGAMP channels","volume":"43","author":"Blest","year":"2024","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1470-2045(20)30540-4","article-title":"Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial","volume":"22","author":"Boorjian","year":"2021","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105222_bib10","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/mc.23753","article-title":"JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway","volume":"63","author":"Cai","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2026.105222_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156980","article-title":"ATM and ATR inhibition increases radiosensitivity and cGAS-STING activation in prostate cancer","volume":"193","author":"van Campen","year":"2025","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105222_bib12","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1158\/0008-5472.CAN-21-0628","article-title":"PBRM1 deficiency confers synthetic lethality to DNA repair inhibitors in cancer","volume":"81","author":"Chabanon","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib13","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1038\/s41467-024-54293-z","article-title":"Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy","volume":"15","author":"Choi","year":"2024","journal-title":"Nat. Commun."},{"issue":"39","key":"10.1016\/j.critrevonc.2026.105222_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2514948122","article-title":"PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors","volume":"122","author":"Chowdhury","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12951-024-02496-3","article-title":"Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis","volume":"22","author":"Deng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.critrevonc.2026.105222_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2023.09.024","article-title":"Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer","volume":"363","author":"Ding","year":"2023","journal-title":"J. Control Release J. Control Release Soc."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105222_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500141","article-title":"Synergistic provoking of pyroptosis and STING pathway by multifunctional manganese-polydopamine nano-immunomodulator for enhanced renal cell carcinoma immunotherapy","volume":"14","author":"Du","year":"2025","journal-title":"Adv. Health Mater."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105222_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167270","article-title":"The proto-oncogene SRC phosphorylates cGAS to inhibit an antitumor immune response","volume":"8","author":"Dunker","year":"2023","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105222_bib19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.immuni.2024.02.019","article-title":"New frontiers in the cGAS-STING intracellular DNA-sensing pathway","volume":"57","author":"Dvorkin","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105222_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.621550","article-title":"Combination of interleukin-15 with a STING Agonist, ADU-S100 analog: a potential immunotherapy for prostate cancer","volume":"11","author":"Esteves","year":"2021","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03317-9","article-title":"Ultrasound-induced mechanical damage of cancer cell cytoskeleton causes disruption of nuclear envelope and activation of cGAS-STING","volume":"15","author":"Federico","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105222_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123126","article-title":"Photochemical bomb: precision nuclear targeting to activate cGAS-STING pathway for enhanced bladder cancer immunotherapy","volume":"318","author":"Feng","year":"2025","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105222_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193011","article-title":"Activation of cGAS-STING signal to inhibit the proliferation of bladder cancer: the immune effect of cisplatin","volume":"11","author":"Fu","year":"2022","journal-title":"Cells"},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105222_bib24","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1158\/1078-0432.CCR-23-1439","article-title":"SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression","volume":"29","author":"Geng","year":"2023","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105222_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2545","article-title":"Immunogenic and tolerogenic cell death","volume":"9","author":"Green","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105222_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116494","article-title":"Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer","volume":"272","author":"Guan","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105222_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14671","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in neurodegenerative diseases","volume":"30","author":"Guo","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"7668","key":"10.1016\/j.critrevonc.2026.105222_bib28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105222_bib29","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1158\/1078-0432.CCR-24-3630","article-title":"Phase I and II clinical studies of the STING agonist ulevostinag with and without pembrolizumab in participants with advanced or metastatic solid tumors or lymphomas","volume":"31","author":"Harrington","year":"2025","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105222_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.euf.2025.04.003","article-title":"STARLITE 1: phase 1b\/2 study of combined (177)Lu-girentuximab plus cabozantinib and nivolumab in treatment-na\u00efve patients with advanced clear-cell renal cell carcinoma","volume":"11","author":"Hasanov","year":"2025","journal-title":"Eur. Urol. Focus"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105222_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102804","article-title":"Investigating radiotherapy response in a novel syngeneic model of prostate cancer","volume":"12","author":"Haughey","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105222_bib32","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.immuni.2016.04.010","article-title":"The DNA structure-specific endonuclease MUS81 mediates DNA sensor STING-dependent host rejection of prostate cancer cells","volume":"44","author":"Ho","year":"2016","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105222_bib33","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.7150\/thno.54695","article-title":"Arginine starvation elicits chromatin leakage and cGAS-STING activation via epigenetic silencing of metabolic and DNA-repair genes","volume":"11","author":"Hsu","year":"2021","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105222_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6950","article-title":"Carbon ion irradiation exerts antitumor activity by inducing cGAS-STING activation and immune response in prostate cancer-bearing mice","volume":"13","author":"Hu","year":"2024","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105222_bib35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1158\/1535-7163.MCT-21-0780","article-title":"Pharmacologic activation of STING in the bladder induces potent antitumor immunity in non-muscle invasive murine bladder cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00018-024-05320-1","article-title":"Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancer","volume":"81","author":"Huang","year":"2024","journal-title":"Cell Mol. Life Sci."},{"issue":"7213","key":"10.1016\/j.critrevonc.2026.105222_bib37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105222_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13045-021-01168-1","article-title":"Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway","volume":"14","author":"Ji","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105222_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217808","article-title":"Ketogenesis instigates immune suppression in enzalutamide resistant prostate cancer via OTUD7B \u03b2-hydroxybutyrylation","volume":"625","author":"Jiang","year":"2025","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105222_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110285","article-title":"VHL loss enhances antitumor immunity by activating the anti-viral DNA-sensing pathway","volume":"27","author":"Jiao","year":"2024","journal-title":"iScience"},{"issue":"34","key":"10.1016\/j.critrevonc.2026.105222_bib41","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1038\/s41388-024-03107-z","article-title":"GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-\u03b2 axis-mediated antitumor immunity","volume":"43","author":"Jin","year":"2024","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105222_bib42","article-title":"Estrogen enhanced the expression of IL-17 by tissue-resident memory \u03b3\u03b4T cells from uterus via interferon regulatory factor 4","volume":"36","author":"Kang","year":"2022","journal-title":"FASEB J. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105222_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.molcel.2020.10.021","article-title":"LRRC8A:C\/E heteromeric channels are ubiquitous transporters of cGAMP","volume":"80","author":"Lahey","year":"2020","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105222_bib44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.immuni.2025.03.005","article-title":"Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway","volume":"58","author":"Lai","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105222_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215885","article-title":"BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma","volume":"547","author":"Langbein","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1186\/s12967-023-04743-x","article-title":"Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS\/STING\/IRF3 pathway","volume":"21","author":"Li","year":"2023","journal-title":"J. Transl. Med."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105222_bib47","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1158\/0008-5472.CAN-23-3704","article-title":"CDK4\/6 Alters TBK1 phosphorylation to inhibit the STING signaling pathway in prostate cancer","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105222_bib48","article-title":"RNF216 regulates meiosis and PKA stability in the testes","volume":"35","author":"Li","year":"2021","journal-title":"FASEB J. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.critrevonc.2026.105222_bib49","article-title":"Mining bone metastasis related key genes of prostate cancer from the STING pathway based on machine learning","volume":"11","author":"Li","year":"2024","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105222_bib50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"184","key":"10.1016\/j.critrevonc.2026.105222_bib51","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.24976\/Discov.Med.202436184.95","article-title":"UNC93B1 mediates the effects of cGAS-STING on ER stress and iron death, and reduces renal toxicity in cadmium-exposed rats","volume":"36","author":"Liu","year":"2024","journal-title":"Discov. Med."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105222_bib52","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1158\/1078-0432.CCR-23-1003","article-title":"SETD2 Loss and ATR inhibition synergize to promote cGAS signaling and immunotherapy response in renal cell carcinoma","volume":"29","author":"Liu","year":"2023","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105222_bib53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.5830","article-title":"BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer","volume":"256","author":"Lombardo","year":"2022","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105222_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010511","article-title":"Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors","volume":"13","author":"Luke","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105222_bib55","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","article-title":"Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer","volume":"40","author":"Ma","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib56","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41467-023-41218-5","article-title":"AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105222_bib57","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7150\/thno.73152","article-title":"Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00428-023-03549-y","article-title":"STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma","volume":"483","author":"Marletta","year":"2023","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105222_bib59","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00428-025-04041-5","article-title":"Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications","volume":"487","author":"Marletta","year":"2025","journal-title":"Virchows Arch."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105222_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70088","article-title":"Impact of intra-tumoral immunity on predicting response and survival after neoadjuvant cisplatin-based chemotherapy in patients with muscle invasive bladder cancer","volume":"13","author":"Mendoza-Valderrey","year":"2024","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105222_bib61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib62","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105222_bib63","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s43018-021-00185-w","article-title":"EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer","volume":"2","author":"Morel","year":"2021","journal-title":"Nat. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105222_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103323","article-title":"Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy","volume":"9","author":"Motedayen Aval","year":"2020","journal-title":"J. Clin. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105222_bib65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ccell.2020.04.002","article-title":"Comprehensive molecular characterization identifies distinct genomic and immune hallmarks of renal medullary carcinoma","volume":"37","author":"Msaouel","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010031","article-title":"Cancer immunotherapy with lipid nanoparticles loaded with a stimulator of interferon genes agonist against renal tumor lung metastasis","volume":"16","author":"Nakamura","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105222_bib67","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1158\/1535-7163.MCT-22-0369","article-title":"BET inhibition sensitizes immunologically cold Rb-deficient prostate cancer to immune checkpoint blockade","volume":"22","author":"Olson","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2026.105222_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1196829","article-title":"Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models","volume":"14","author":"Papaevangelou","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41435-018-0029-9","article-title":"TMEM173 variants and potential importance to human biology and disease","volume":"20","author":"Patel","year":"2019","journal-title":"Genes Immun."},{"issue":"25","key":"10.1016\/j.critrevonc.2026.105222_bib70","article-title":"Self-propelled in situ polymerized nanoparticles activating the STING pathway for enhanced bladder cancer immunotherapy","volume":"12","author":"Peng","year":"2025","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105222_bib71","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1158\/0008-5472.CAN-24-1022","article-title":"STING agonist VB-85247 induces durable antitumor immune responses by intravesical administration in a non-muscle-invasive bladder cancer","volume":"85","author":"Prabagar","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105222_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fruro.2023.984967","article-title":"Mutations in genes encoding innate immune molecules identified in bladder cancer samples as potential biomarkers for immunotherapy with BCG and agonists","volume":"3","author":"de Queiroz","year":"2023","journal-title":"Front. Urol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105222_bib73","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.7150\/jca.90439","article-title":"Higher concentration of P7C3 than required for neuroprotection suppresses renal cell carcinoma growth and metastasis","volume":"15","author":"Shu","year":"2024","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib74","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41467-022-28509-z","article-title":"Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer","volume":"13","author":"Singh","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105222_bib75","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","article-title":"Role of the cGAS-STING pathway in systemic and organ-specific diseases","volume":"18","author":"Skopelja-Gardner","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105222_bib76","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1158\/2767-9764.CRC-22-0047","article-title":"Classifying cGAS-STING activity links chromosomal instability with immunotherapy response in metastatic bladder cancer","volume":"2","author":"Soka\u010d","year":"2022","journal-title":"Cancer Res. Commun."},{"issue":"28","key":"10.1016\/j.critrevonc.2026.105222_bib77","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2413732122","article-title":"DNA2 protein destruction dictates DNA hyperexcision, cGAS-STING activation, and innate immune response in CDK12-deregulated cancers","volume":"122","author":"Sun","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6121","key":"10.1016\/j.critrevonc.2026.105222_bib78","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib79","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1038\/s41598-021-86644-x","article-title":"cGAS-STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells","volume":"11","author":"Suter","year":"2021","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105222_bib80","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/1078-0432.CCR-21-1010","article-title":"ATR inhibition induces CDK1-SPOP signaling and enhances Anti-PD-L1 cytotoxicity in prostate cancer","volume":"27","author":"Tang","year":"2021","journal-title":"Clin. Cancer Res J. Am. Assoc. Cancer Res"},{"issue":"35","key":"10.1016\/j.critrevonc.2026.105222_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202308890","article-title":"Activation of the cGAS-STING-IRF3 axis by type I and II interferons contributes to host defense","volume":"11","author":"Tong","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib82","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2466305","article-title":"Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses","volume":"14","author":"Turpin","year":"2025","journal-title":"Oncoimmunology"},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105222_bib83","article-title":"PEGylated manganese-zinc ferrite nanocrystals combined with intratumoral implantation of micromagnets enabled synergetic prostate cancer therapy via ferroptotic and immunogenic cell death","volume":"19","author":"Wang","year":"2023","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.kint.2020.08.028","article-title":"Immune evasion in renal cell carcinoma: biology, clinical translation, future directions","volume":"99","author":"Wang","year":"2021","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105222_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17071184","article-title":"ALDH1A3 regulates cellular senescence and senescence-associated secretome in prostate cancer","volume":"17","author":"Wang","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308762","article-title":"Targeting DNA damage and repair machinery via delivering WEE1 inhibitor and platinum (IV) prodrugs to stimulate STING pathway for maximizing chemo-immunotherapy in bladder cancer","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105222_bib87","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s11010-024-04970-w","article-title":"STING agonist, SMA-2, inhibits clear cell renal cell carcinoma through improving tumor microenvironment","volume":"479","author":"Wang","year":"2024","journal-title":"Mol. Cell Biochem."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105222_bib88","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105222_bib89","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.18632\/aging.205442","article-title":"Molecular map of cGAS-STING pathway-related genes in bladder cancer: the perspective toward immune microenvironment and prognosis","volume":"16","author":"Wei","year":"2024","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105222_bib90","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"33","key":"10.1016\/j.critrevonc.2026.105222_bib91","doi-asserted-by":"crossref","first-page":"43257","DOI":"10.1021\/acsami.4c07072","article-title":"Optimized bionic drug-delivery-inducing immunogenic cell death and cGAS-STING pathway activation for enhanced photodynamic-chemotherapy-driven immunotherapy in prostate cancer","volume":"16","author":"Wu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.critrevonc.2026.105222_bib92","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.2147\/IJGM.S328225","article-title":"Overexpression of IRF3 predicts poor prognosis in clear cell renal cell carcinoma","volume":"14","author":"Wu","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.critrevonc.2026.105222_bib93","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7978042","article-title":"Identification of cytosolic DNA sensor cGAS-STING as immune-related risk factor in renal carcinoma following pan-cancer analysis","volume":"2022","author":"Wu","year":"2022","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105222_bib94","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.it.2023.04.006","article-title":"Structure-based mechanisms of 2\u20193\u2019-cGAMP intercellular transport in the cGAS-STING immune pathway","volume":"44","author":"Xie","year":"2023","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib95","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41392-023-01378-8","article-title":"Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib96","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1186\/s12885-024-12492-3","article-title":"Identification of the cytoplasmic DNA-Sensing cGAS-STING pathway-mediated gene signatures and molecular subtypes in prostate cancer","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105222_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28803","article-title":"Stimulator of interferon genes mediated immune senescence reveals the immune microenvironment and prognostic characteristics of bladder cancer","volume":"10","author":"Yao","year":"2024","journal-title":"Heliyon"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105222_bib98","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-25-1667","article-title":"Resilience and vulnerabilities of tumor cells under purine shortage stress","volume":"31","author":"Yu","year":"2025","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib99","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41467-025-56922-7","article-title":"Phosphorylation of FOXN3 by NEK6 promotes pulmonary fibrosis through Smad signaling","volume":"16","author":"Yu","year":"2025","journal-title":"Nat. Commun."},{"issue":"7952","key":"10.1016\/j.critrevonc.2026.105222_bib100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41586-023-05770-w","article-title":"Fumarate induces vesicular release of mtDNA to drive innate immunity","volume":"615","author":"Zecchini","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105222_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215829","article-title":"Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING\/MAVS signaling pathway","volume":"545","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105222_bib102","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1038\/s41418-019-0302-0","article-title":"STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib103","first-page":"45","article-title":"Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies","volume":"21","author":"Zhang","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2026.105222_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116990","article-title":"Coumarin-Quinazolinone based photosensitizers: Mitochondria and endoplasmic reticulum targeting for enhanced phototherapy via different cell death pathways","volume":"280","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105222_bib105","doi-asserted-by":"crossref","first-page":"16112","DOI":"10.1063\/5.0250173","article-title":"PCBP2 promotes immune evasion via cGAS-STING pathway in biochemical recurrence of prostate cancer","volume":"9","author":"Zhou","year":"2025","journal-title":"APL Bioeng."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105222_bib106","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1158\/0008-5472.CAN-23-0401","article-title":"SETD2 deficiency confers sensitivity to dual inhibition of DNA methylation and PARP in kidney cancer","volume":"83","author":"Zhou","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105222_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118209","article-title":"Revealing the role of bisphenol A on prostate cancer progression and identifying potential targets: a comprehensive analysis from population cohort to molecular mechanism","volume":"296","author":"Zhou","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105222_bib108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00018-023-04796-7","article-title":"Development of VHL-recruiting STING PROTACs that suppress innate immunity","volume":"80","author":"Zhu","year":"2023","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105222_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203718","article-title":"STING Suppresses Mitochondrial VDAC2 to Govern RCC Growth Independent of Innate Immunity","volume":"10","author":"Zhu","year":"2023","journal-title":"Adv. Sci."},{"issue":"50","key":"10.1016\/j.critrevonc.2026.105222_bib110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031290","article-title":"The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma","volume":"101","author":"Zhuo","year":"2022","journal-title":"Medicine"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:38:11Z","timestamp":1778794691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":110,"alternative-id":["S1040842826001095"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105222","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"cGAS\u2013STING signaling pathway in urogenital oncology: Regulation, resistance, and routes to response","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105222"}}